Coronavirus Disease 2019 (COVID-19) Vaccine Prioritization in Low- And Middle-Income Countries May Justifiably Depart from High-Income Countries’ Age Priorities

Nir Eyal*, Anca Gheaus, Axel Gosseries, Monica Magalhaes, Thierry Ngosso, Bastian Steuwer, Viroj Tangcharoensathien, Isa Trifan, Andrew Williams

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract (may include machine translation)

In high-income countries that were first to roll out coronavirus disease 2019 (COVID-19) vaccines, older adults have thus far usually been prioritized for these vaccines over younger adults. Age-based priority primarily resulted from interpreting evidence available at the time, which indicated that vaccinating the elderly first would minimize COVID-19 deaths and hospitalizations. The World Health Organization counsels a similar approach for all countries. This paper argues that some low- and middle-income countries that are short of COVID-19 vaccine doses might be justified in revising this approach and instead prioritizing certain younger persons when allocating current vaccines or future variant-specific vaccines.

Original languageEnglish
Pages (from-to)S93-S97
JournalClinical Infectious Diseases
Volume75
DOIs
StatePublished - 15 Aug 2022

Keywords

  • COVID-19
  • age-based prioritization
  • developing countries
  • healthcare rationing
  • vaccines

Fingerprint

Dive into the research topics of 'Coronavirus Disease 2019 (COVID-19) Vaccine Prioritization in Low- And Middle-Income Countries May Justifiably Depart from High-Income Countries’ Age Priorities'. Together they form a unique fingerprint.

Cite this